blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3446693

EP3446693 - PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS COMPRISING ALUMINIUM ACETATE FOR TOPICAL APPLICATION WITH ASTRINGENT AND ANTIMICROBIAL EFFECT [Right-click to bookmark this link]
Former [2019/09]PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS FOR TOPICAL APPLICATION WITH ASTRINGENT AND ANTIMICROBIAL EFFECT
[2020/24]
StatusNo opposition filed within time limit
Status updated on  17.09.2021
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  09.10.2020
FormerGrant of patent is intended
Status updated on  27.05.2020
FormerRequest for examination was made
Status updated on  23.08.2019
FormerThe application has been published
Status updated on  25.01.2019
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
Hiantis S.r.l.
Via Sofonisba Anguissola, 2
20146 Milano / IT
[2019/09]
Inventor(s)01 / ROMANO, Paolo
Via Sofonisba Anguissola, 2
20146 Milano / IT
 [2019/09]
Representative(s)Ferreccio, Rinaldo
Botti & Ferrari S.p.A.
Via Cappellini, 11
20124 Milano / IT
[N/P]
Former [2019/09]Ferreccio, Rinaldo
Botti & Ferrari S.r.l. Via Cappellini, 11
20124 Milano / IT
Application number, filing date18197035.115.02.2016
[2019/09]
Priority number, dateIT2015MI0024319.02.2015         Original published format: IT MI20150243
[2019/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3446693
Date:27.02.2019
Language:EN
[2019/09]
Type: B1 Patent specification 
No.:EP3446693
Date:11.11.2020
Language:EN
[2020/46]
Search report(s)(Supplementary) European search report - dispatched on:EP29.01.2019
ClassificationIPC:A61K33/06, A61K31/185, A61K31/19, A61P17/00, A61P17/02, A61P17/04, A61K31/18, A61K33/32, A61K45/06
[2019/09]
CPC:
A61K31/19 (EP); A61K31/18 (EP); A61K31/185 (EP);
A61K33/06 (EP); A61K33/32 (EP); A61K45/06 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/04 (EP) (-)
C-Set:
A61K31/185, A61K2300/00 (EP);
A61K31/18, A61K2300/00 (EP);
A61K31/19, A61K2300/00 (EP);
A61K33/06, A61K2300/00 (EP);
A61K33/32, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/39]
Former [2019/09]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND FORMULIERUNGEN ENTHALTEND ALUMINIUMACETAT ZUR TOPISCHEN ANWENDUNG MIT ADSTRINGIERENDER UND ANTIMIKROBIELLER WIRKUNG[2020/24]
English:PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS COMPRISING ALUMINIUM ACETATE FOR TOPICAL APPLICATION WITH ASTRINGENT AND ANTIMICROBIAL EFFECT[2020/24]
French:COMPOSITIONS PHARMACEUTIQUES ET FORMULATIONS COMPRENANT DE L ́ACÉTATE D'ALUMINIUM POUR APPLICATION TOPIQUE AVEC EFFET ASTRINGENT ET ANTIMICROBIEN[2020/24]
Former [2019/09]PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND FORMULIERUNGEN ZUR TOPISCHEN ANWENDUNG MIT ADSTRINGIERENDER UND ANTIMIKROBIELLER WIRKUNG
Former [2019/09]PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS FOR TOPICAL APPLICATION WITH ASTRINGENT AND ANTIMICROBIAL EFFECT
Former [2019/09]COMPOSITIONS PHARMACEUTIQUES ET FORMULATIONS POUR APPLICATION TOPIQUE AVEC EFFET ASTRINGENT ET ANTIMICROBIEN
Examination procedure20.08.2019Amendment by applicant (claims and/or description)
20.08.2019Examination requested  [2019/39]
20.08.2019Date on which the examining division has become responsible
28.05.2020Communication of intention to grant the patent
29.09.2020Fee for grant paid
29.09.2020Fee for publishing/printing paid
29.09.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP16155637.8  / EP3058945
Opposition(s)12.08.2021No opposition filed within time limit [2021/42]
Fees paidRenewal fee
27.09.2018Renewal fee patent year 03
20.02.2019Renewal fee patent year 04
20.02.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.02.2016
AL11.11.2020
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
MK11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
[2024/23]
Former [2023/33]HU15.02.2016
AL11.11.2020
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2023/30]AL11.11.2020
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2022/34]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
BE28.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2022/23]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2022/10]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
CH28.02.2021
LI28.02.2021
PT11.03.2021
Former [2022/07]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IE15.02.2021
LU15.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/50]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU15.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/48]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
IT11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU15.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/46]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
LU15.02.2021
CH28.02.2021
LI28.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/45]AL11.11.2020
AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/41]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/37]AT11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/36]AT11.11.2020
CZ11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/35]AT11.11.2020
CZ11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RO11.11.2020
RS11.11.2020
SE11.11.2020
SK11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/33]AT11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
PL11.11.2020
RS11.11.2020
SE11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/32]AT11.11.2020
FI11.11.2020
HR11.11.2020
LV11.11.2020
PL11.11.2020
RS11.11.2020
SE11.11.2020
SM11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/28]AT11.11.2020
FI11.11.2020
HR11.11.2020
LV11.11.2020
PL11.11.2020
RS11.11.2020
SE11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/25]AT11.11.2020
FI11.11.2020
LV11.11.2020
PL11.11.2020
RS11.11.2020
SE11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
Former [2021/23]AT11.11.2020
FI11.11.2020
LV11.11.2020
RS11.11.2020
SE11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
PT11.03.2021
Former [2021/22]FI11.11.2020
RS11.11.2020
NO11.02.2021
PT11.03.2021
Former [2021/21]FI11.11.2020
PT11.03.2021
Former [2021/20]FI11.11.2020
Documents cited:SearchCN101474421  [ ];
 [A]US6656928  (MCCADDEN MICHAEL E [US]) [A] 1-5* abstract *;
 [A]US2005191366  (MCCADDEN MICHAEL E [US]) [A] 1-5 * claims 1-3 *;
 [A]CN101474421  (PEIRONG SONG [CN]) [A] 1-5 * abstract *;
 [A]US7790771  (RAPP HORST [DE], et al) [A] 1-5 * abstract *;
    [ ] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2009, no. 54, Database accession no. 2009-L62420, XP002757036 & CN101474421 A 20090708 (SONG P) [ ] * abstract *
by applicantUS2824042
    - ALLEN, LOYD V., JR., Remington's Pharmaceutical Sciences
    - THORP MA; GARDINER IB; PRESCOTT CA, "Burow's solution in the treatment of active mucosal chronic suppurative otitis media: determining an effective dilution", J Laryngol Otol., (20000600), vol. 114, no. 6, pages 432 - 6
    - THORP MA; OLIVER SP; KRUGER J; PRESCOTT CA, "Determination of the lowest dilution of aluminium acetate solution able to inhibit in vitro growth of organisms commonly found in chronic suppurative otitis media", J Laryngol Otol., (20001100), vol. 114, no. 11, pages 830 - 1
    - "Food and Drug Administration, HHS. Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment", Fed Regist., (20090306), vol. 74, no. 43, pages 9759 - 65
    - HSIEH MH; YU CM; YU VL; CHOW JW, "Synergy assessed by checkerboard. A critical analysis", Diagn Microbiol Infect Dis., (19930500), vol. 16, no. 4, doi:doi:10.1016/0732-8893(93)90087-N, pages 343 - 9, XP023915582

DOI:   http://dx.doi.org/10.1016/0732-8893(93)90087-N
    - WHITE RL; BURGESS DS; MANDURU M; BOSSO JA, "Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test", Antimicrob Agents Chemother, (19960800), vol. 40, no. 8, pages 1914 - 8, XP055052950
    - CHEN YL; LEHMAN VN; AVERETTE AF; PERFECT JR; HEITMAN J, Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans
    - PERRINS N; HOWELL SA; MOORE M; BOND R, "Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine", Vet Dermatol., (20051000), vol. 16, no. 5, pages 330 - 3
    - SOPIRALA MM; MANGINO JE; GEBREYES WA; BILLER B; BANNERMAN T; BALADA-LLASAT JM; PANCHOLI P, "Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii", Antimicrob Agents Chemother, (20101100), vol. 54, no. 11, doi:doi:10.1128/AAC.00497-10, pages 4678 - 83, XP055151857

DOI:   http://dx.doi.org/10.1128/AAC.00497-10
    - DOVI JV; HE LK; DIPIETRO LA, "Accelerated wound closure in neutrophil-depleted mice", J Leukoc Biol., (20030400), vol. 73, no. 4, pages 448 - 55
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.